Bioactive compounds and probiotics–a ray of hope in COVID-19 management
Indu Bhushan, Mahima Sharma, Malvika Mehta, Shivi Badyal, Varun Sharma, Indu Sharma, Hemender Singh, Srinivas Sistla
Abstract
The use of bioactive compounds and probiotic bacteria against the viral diseases in human is known for a long time. Anti-viral, anti-inflammatory and anti-allergic properties of bioactive compounds and bacteria with probiotic properties in respiratory viral diseases may have significance to enhance immunity. This review highlights some of the important bioactive compounds and probiotic bacteria, suggesting them as a ray of hope in the milieu of the COVID-19 management.
Topics & Concepts
ProbioticBacteriaCoronavirus disease 2019 (COVID-19)BiologyMicrobiologyImmunityMedicineImmunologyImmune systemDiseaseInfectious disease (medical specialty)Internal medicineGeneticsViral gastroenteritis research and epidemiologyProbiotics and Fermented FoodsGut microbiota and health